Sullivan Street Partners has acquired UKAT, which provides addiction treatment services and offers more than 200 beds across eight facilities.

Spire Healthcare Group has reported first-half 2024 adjusted profit after tax of £19.6 million, up 38% on the £14.2 million reported for the first half of 2023.

Celadon Pharmaceuticals which focuses on the development, production and sale of cannabis-based medicines, has raised £1.05 million through the issue of shares.